Log In
Print
BCIQ
Print
Print this Print this
 

Epogen, epoetin alfa

Also known as: Epoetin alfa/Epoetin beta, erythropoietin

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionErythropoietin (EPO) receptor agonist
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsMaintain hematocrit in dialysis patients; Red blood cell stimulation in end-stage renal disease (ESRD); Treat anemia; Treat anemia associated with chemotherapy; Treat anemia associated with chronic renal failure (CRF); Treat anemia in dialysis patients; Treat anemia in patients with chronic kidney disease (CKD); Treat anemia in zidovudine-treated HIV-infected patients; Treat chemotherapy-induced anemia (CIA) in patients with cancer; Treat dialysis patients with cardiovascular disease (CVD); Treat patients with cardiac disease on hemodialysis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today